Duffy SJ - Search Results

1

Treatment of hypertension with ascorbic acid.

Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, Vita JA. Duffy SJ, et al. Lancet. 1999 Dec 11;354(9195):2048-9. doi: 10.1016/s0140-6736(99)04410-4. Lancet. 1999. PMID: 10636373 Free article. Clinical Trial.

2

Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.

Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, Maxwell C, Palmisano J, Keaney JF Jr, Morrow JD, Vita JA. Widlansky ME, et al. Among authors: duffy sj. Hypertension. 2003 Sep;42(3):310-5. doi: 10.1161/01.HYP.0000084603.93510.28. Epub 2003 Jul 21. Hypertension. 2003. PMID: 12874094 Clinical Trial.

3

Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid.

Widlansky ME, Biegelsen ES, Hamburg NM, Duffy SJ, Keaney JF Jr, Vita JA. Widlansky ME, et al. Among authors: duffy sj. Free Radic Biol Med. 2004 Jan 1;36(1):123-30. doi: 10.1016/j.freeradbiomed.2003.10.016. Free Radic Biol Med. 2004. PMID: 14732296 Clinical Trial.

4

Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension.

Sherman DL, Keaney JF Jr, Biegelsen ES, Duffy SJ, Coffman JD, Vita JA. Sherman DL, et al. Among authors: duffy sj. Hypertension. 2000 Apr;35(4):936-41. doi: 10.1161/01.hyp.35.4.936. Hypertension. 2000. PMID: 10775565

5

Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension.

Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biegelsen ES, Huang A, Keaney JF Jr, Vita JA. Duffy SJ, et al. Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H528-34. doi: 10.1152/ajpheart.2001.280.2.H528. Am J Physiol Heart Circ Physiol. 2001. PMID: 11158948 Free article. Clinical Trial.

6

Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery.

Gokce N, Holbrook M, Duffy SJ, Demissie S, Cupples LA, Biegelsen E, Keaney JF Jr, Loscalzo J, Vita JA. Gokce N, et al. Among authors: duffy sj. Hypertension. 2001 Dec 1;38(6):1349-54. doi: 10.1161/hy1201.096575. Hypertension. 2001. PMID: 11751716 Clinical Trial.

7

Effects of black race on forearm resistance vessel function.

Kahn DF, Duffy SJ, Tomasian D, Holbrook M, Rescorl L, Russell J, Gokce N, Loscalzo J, Vita JA. Kahn DF, et al. Among authors: duffy sj. Hypertension. 2002 Aug;40(2):195-201. doi: 10.1161/01.hyp.0000024571.69634.ed. Hypertension. 2002. PMID: 12154113 Clinical Trial.

8

Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease.

Vita JA, Gokce N, Duffy SJ, Kahn D, Tomasian D, Palmisano J, Thomas S, Holbrook M, Keaney JF Jr. Vita JA, et al. Among authors: duffy sj. Am J Cardiol. 2003 Apr 1;91(7):857-60. doi: 10.1016/s0002-9149(03)00019-5. Am J Cardiol. 2003. PMID: 12667571 Clinical Trial. No abstract available.

9

Iron chelation improves endothelial function in patients with coronary artery disease.

Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA. Duffy SJ, et al. Circulation. 2001 Jun 12;103(23):2799-804. doi: 10.1161/01.cir.103.23.2799. Circulation. 2001. PMID: 11401935 Clinical Trial.

10

Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease.

Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Duffy SJ, et al. Circulation. 2001 Jul 10;104(2):151-6. doi: 10.1161/01.cir.104.2.151. Circulation. 2001. PMID: 11447078 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters